Walgreens Boots Alliance, Inc.

Walgreens Boots Alliance operates as a healthcare, pharmacy, and retail company globally. It has three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment offers retail drugstores, health services, and home delivery pharmacy services. The International segment sells prescription drugs and consumer products outside the US. The Boots brand operates in the UK, Ireland, Thailand, Mexico, and Chile. The U.S. Healthcare segment provides value-based care, specialty pharmacy integrator, and post-acute care management.

Overview

Sector

Pharmaceutical Retailers

Target Price

0.0 USD

Current Price

11.3 USD

Potential

-100%

Strengths

No significant strengths identified based on the analyzed metrics.

Weaknesses

With a depreciation Potential of -100.00%, based on our fundamental analysis, it suggests the stock may be overvalued.
Current Price to Earnings Ratio (100.00) is significantly higher than the sector mean (71.63).
Analysts expect revenues to decline in the coming year.
The company has high debt. Net Debt to EBITDA Ratio (5.78) is higher than the sector mean.
EBITDA Margin (0.96%) appears relatively low.

Key Financial Data

Indicator	Value
PER	100.0
EV/EBITDA	12.7
Price/Free Cash Flow'	100.0
ROIC	5.1%
Net Debt/EBITDA	5.8